For example, we observed that genes involved in lipid and FFA metabolism, such as APOC1, APOA2, PPARA, and FADS2, were down-regulated in both treated HepG2 cells and NAFLD livers (Figure S3A–D). Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.